Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

12 Health Care Stocks Moving In Wednesday’s Intraday Session

 

 

Gainers

  • Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday’s regular session. Trading volume for this security as of 12:30 EST is 48.8 million, which is 2745.29% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $127.5 million.
  • CohBar (NASDAQ:CWBR) shares moved upwards by 24.8% to $1.61. As of 12:30 EST, this security is trading at a volume of 127.3 million shares, making up 23210.23% of its average full-day volume over the last 100 days. The company’s market cap stands at $99.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Plus Therapeutics (NASDAQ:PSTV) stock moved upwards by 18.25% to $2.21. The current volume of 2.0 million shares is 525.1% of Plus Therapeutics’s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $26.7 million.
  • Allied Healthcare Prods (NASDAQ:AHPI) shares moved upwards by 14.13% to $12.27. As of 12:30 EST, Allied Healthcare Prods’s stock is trading at a volume of 18.4 million, which is 225.62% of its average full-day volume over the last 100 days. The company’s market cap stands at $49.2 million.
  • Clearside Biomedical (NASDAQ:CLSD) shares rose 10.52% to $5.46. Clearside Biomedical’s stock is trading at a volume of 570.3K shares as of 12:30 EST. This is 18.79% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $314.3 million. The company’s, Q2 earnings came out yesterday.
  • Achieve Life Sciences (NASDAQ:ACHV) stock increased by 9.3% to $7.87. Achieve Life Sciences’s stock is trading at a volume of 239.2K shares as of 12:30 EST. This is 98.87% of its average full-day volume over the last 100 days. The company’s market cap stands at $74.3 million.

 

 

Losers

 

  • Biodesix (NASDAQ:BDSX) shares decreased by 22.87% to $7.59 during Wednesday’s regular session. Trading volume for this security as of 12:30 EST is 311.0K, which is 239.94% of its average full-day volume over the last 100 days. The company’s market cap stands at $203.8 million. As per the press release, Q2 earnings came out yesterday.
  • OncoCyte (NASDAQ:OCX) stock declined by 18.81% to $4.06. As of 12:30 EST, this security is trading at a volume of 914.2K shares, making up 207.71% of its average full-day volume over the last 100 days. The company’s market cap stands at $371.3 million. As per the press release, Q2 earnings came out yesterday.
  • ClearPoint Neuro (NASDAQ:CLPT) stock decreased by 17.64% to $18.03. As of 12:30 EST, ClearPoint Neuro’s stock is trading at a volume of 897.9K, which is 241.2% of its average full-day volume over the last 100 days. The company’s market cap stands at $374.3 million. The company’s, Q2 earnings came out yesterday.
  • Inari Medical (NASDAQ:NARI) shares decreased by 17.01% to $73.79. The current volume of 1.6 million shares is 327.12% of Inari Medical’s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $3.6 billion. As per the news, the Q2 earnings report came out yesterday.
  • Moderna (NASDAQ:MRNA) stock fell 15.38% to $386.53. Trading volume for this security as of 12:30 EST is 34.6 million, which is 246.93% of its average full-day volume over the last 100 days. The company’s market cap stands at $156.0 billion. As per the press release, Q2 earnings came out 4 days ago.
  • Day One Biopharmaceutical (NASDAQ:DAWN) stock fell 13.91% to $22.1. As of 12:30 EST, Day One Biopharmaceutical’s stock is trading at a volume of 65.2K, which is 43.35% of its average full-day volume over the last 100 days. The company’s market cap stands at $1.3 billion. As per the news, the Q2 earnings report came out yesterday.

 

 

Total
0
Shares
Related Posts
Read More

How The FOMC Announcement Affected Precious Metal Prices

Precious metals stocks and precious metals reacted positively to Federal Reserve Chairman Jerome Powell’s announcement that interest rates will by 0.75%. Because this sector is traditionally considered an inflation hedge — although not so much lately — the slightly upward move may be a little surprising. 

GDX